Bryan Hanson, head of Medtronic's minimally invasive treatment business group, said in a speech at Medtronic Investor Day that surgical robots will bring "substantial revenue" in FY 2019. In robot-assisted surgery, the surgeon can use the computer to guide the robot's robotic arm for manipulation. This type of incision is smaller and is increasingly being used in prostate and hysterectomy compared to conventional surgery. It is understood that after the listing, Medtronic will compete with Intuitive Surgical's Da Vinci robot, the only robot currently used on the market for abdominal surgery. In addition, competitors are expected to have Verb Surgical, which is developing a robot, and Verb is a startup jointly supported by Johnson & Johnson and Google. Medtronic entered the field of surgical robots to reduce the costs associated with robotic surgery. Hanson said: "The current related costs are high. We will seek ways to clear the barriers in this regard." Medtronic, based in Minneapolis, currently employs 150 people in surgical robotics, located in Massa, USA, Connecticut, Colorado, and Germany. Medtronic products cover pacemakers, heart valves, spinal implants and more. On Medtronic Investment Day, Medtronic also announced plans to introduce hip and knee replacement devices as part of the hospital's orthopaedic solution. It is reported that Medtronic has acquired a company called Responsive Orthopedics to produce these devices. It is expected that knee replacement equipment will be available in the first half of 2017, and hip replacement equipment will be available again in a year. Diagnosis Device,Medical Diagnosis Devices,Diagnosis Therapy Device,Health Diagnosis Device Medton Medical , https://www.medtonmedical.com